#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transferrin decreased Phenylketonuria IPEX syndrome Mantle cell lymphoma recurrent Systemic scleroderma Glomerulonephritis minimal lesion Alexander disease Familial haemophagocytic lymphohistiocytosis Sarcoma Erythema multiforme Retinitis pigmentosa Non-small cell lung cancer recurrent Central nervous system lymphoma Red blood cell abnormality Proteus syndrome More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Diagnostics Leiomyosarcoma metastatic Pituitary-dependent Cushing’s syndrome Hairy cell leukaemia recurrent – Trials in Disease Leiomyosarcoma – Trials in Disease Niemann-Pick disease Hairy cell leukaemia recurrent – Basic Information Burkitt’s lymphoma – Trials in Disease Optic glioma – Life with Disease Splenic marginal zone lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nvdx3 ATIRMOCICLIB Donepezil Hydrochloride Defactinib [18F]Alf-Nota-Octreotide Resamirigene Bilparvovec Amniotic Membrane, Human Cobicistat Vaborbactam VOROLANIB Prednisone Acetate Stro-002 Navitoclax Lovo-A Finerenone Oms906 Emactuzumab Spesolimab Tas3351 Mirabegron More therapies…

    Learn about Your Condition

    Small intestine adenocarcinoma Lung transplant rejection Colorectal cancer stage II Pleomorphic leiomyosarcoma Orthostatic hypotension Dystonic tremor COVID-19 Glioblastoma multiforme Gastrointestinal carcinoma Breast conserving surgery Liposarcoma recurrent Post-acute COVID-19 syndrome Tympanic membrane perforation B-cell type acute leukaemia Nephrogenic anaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mucous membrane pemphigoid

  • Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Mucous membrane pemphigoid
    • Polymyositis
    • Dermatomyositis
    Investigated Drugs:
    • Aldesleukin
    • Glucose
    Germany

  • Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Mucous membrane pemphigoid
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Lactose
    • Glucose
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!